Literature DB >> 16023828

Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder.

Jennifer L Pike1, Michael R Irwin.   

Abstract

Major depressive disorder is associated with increases in infectious disease risk as well as the incidence of inflammatory disorders. Declines of natural killer (NK) cell activity are reliably found in depression, whereas other studies report evidence of inflammation in depressed patients. The potential association between NK activity and circulating markers of immune activation has not been previously examined in the context of major depression. In this study, we measured levels of NK activity, circulating levels of interleukin-6 (IL-6), soluble interleukin-2 receptor, and acute phase proteins in 25 male patients with current major depressive disorder and 25 age, gender, and body weight comparable controls. As compared to controls, patients with major depressive disorder showed lower NK activity (p = .05) and higher circulating levels of IL-6 (p < .05). Levels of NK activity were not correlated with IL-6 or with other markers of immune activation. The independent effect of depression on inflammatory markers and natural killer immune responses has implications for understanding individual differences in the adverse health effects of major depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023828     DOI: 10.1016/j.bbi.2005.05.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  23 in total

Review 1.  Adolescent-Onset Depression: Are Obesity and Inflammation Developmental Mechanisms or Outcomes?

Authors:  Michelle L Byrne; Neil M O'Brien-Simpson; Sarah A Mitchell; Nicholas B Allen
Journal:  Child Psychiatry Hum Dev       Date:  2015-12

Review 2.  Stress and support for parents of youth with bipolar disorder.

Authors:  Redha B Nadkarni; Mary A Fristad
Journal:  Isr J Psychiatry Relat Sci       Date:  2012       Impact factor: 0.481

3.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 4.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.

Authors:  George M Slavich; Michael R Irwin
Journal:  Psychol Bull       Date:  2014-01-13       Impact factor: 17.737

5.  Role of inflammatory cytokines in depression: Focus on interleukin-1β.

Authors:  Rai Khalid Farooq; Kashif Asghar; Shahzina Kanwal; Ali Zulqernain
Journal:  Biomed Rep       Date:  2016-11-10

6.  Major depressive disorder and immunity to varicella-zoster virus in the elderly.

Authors:  Michael R Irwin; Myron J Levin; Carmen Carrillo; Richard Olmstead; Anne Lucko; Nancy Lang; Michael J Caulfield; Adriana Weinberg; Ivan S F Chan; Jim Clair; Jeff G Smith; R D Marchese; Heather M Williams; Danielle J Beck; Patricia T McCook; Gary Johnson; Michael N Oxman
Journal:  Brain Behav Immun       Date:  2011-02-15       Impact factor: 7.217

7.  Immune function and health outcomes in women with depression.

Authors:  Cherie Howk; Mary Bennett
Journal:  Biopsychosoc Med       Date:  2010-05-03

8.  Experienced homophobia and gene expression alterations in Black and Latino men who have sex with men in Los Angeles County.

Authors:  Michael J Li; Sae Takada; Chukwuemeka N Okafor; Pamina M Gorbach; Steven J Shoptaw; Steven W Cole
Journal:  Brain Behav Immun       Date:  2019-09-26       Impact factor: 7.217

9.  Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Authors:  Aric A Prather; Mordechai Rabinovitz; Bruce G Pollock; Francis E Lotrich
Journal:  Brain Behav Immun       Date:  2009-07-15       Impact factor: 7.217

10.  Glucocorticoids regulate natural killer cell function epigenetically.

Authors:  Justin L Eddy; Karen Krukowski; Linda Janusek; Herbert L Mathews
Journal:  Cell Immunol       Date:  2014-06-18       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.